U.S. Markets open in 58 mins

Itamar Medical Ltd. (ITMMF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.57000.0000 (0.00%)
At close: 1:05PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.5700
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.5700 - 0.5700
52 Week Range0.1400 - 0.6400
Avg. Volume1,664
Market Cap357.27M
Beta (5Y Monthly)0.58
PE Ratio (TTM)N/A
EPS (TTM)-0.0240
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Itamar Medical to Report Second Quarter Financial Results and Host Conference Call on Tuesday, August 11, 2020

    CAESAREA, Israel, July 27, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders, announced today that it will report its unaudited financial results for the second quarter 2020 before the U.S. market opens on Tuesday, August 11, 2020. The Company will host a conference call that day at 8:00 a.m. Eastern Time, 3:00 p.m. Israel Time to review financial results and provide a corporate update. The call will be hosted by Gilad Glick, President and CEO, and Shy Basson, CFO & US COO.To listen live via webcast, please visit https://ir.itamar-medical.com/.To participate via phone, please use the following dial in information: U.S. toll-free: 833-519-1272 International: 914-800-3844 Israel toll-free: 1-809-315-362 Conference ID: 8798951Please log in approximately 10 minutes prior to the scheduled start time. The archived webcast will be available in the Events and Presentations section of the Company’s website for at least 60 days following the call.About Itamar Medical Ltd. Itamar Medical is a medical technology company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders. Itamar Medical commercializes a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the core sleep, cardiology and direct to consumer markets. Itamar Medical offers a Total Sleep Solution to help physicians provide comprehensive sleep apnea management in a variety of clinical environments to optimize patient care and reduce healthcare system costs. Itamar Medical is a public company traded on the Nasdaq and on the Tel Aviv Stock Exchanges, and is based in Caesarea, Israel with U.S. headquarters based in Atlanta, GA. For additional information visit www.itamar-medical.com.Forward-Looking Statements This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and other applicable securities laws. Statements preceded by, followed by, or that otherwise include the words "believes", "expects", "anticipates", "intends", "estimates", "plans", and similar expressions or future or conditional verbs such as "will", "should", "would", "may" and "could" are generally forward-looking in nature and not historical facts. Because such statements deal with future events, they are subject to various risks, uncertainties and assumptions, including events and circumstances out of the Company's control and actual results, expressed or implied by such forward-looking statements, could differ materially from the Company's current expectations. Factors that could cause or contribute to such differences include, but are not limited to, risks, uncertainties and assumptions discussed from time to time by the Company in reports filed with, or furnished to, the U.S. Securities and Exchange Commission (“SEC”) and the Israel Securities Authority (“ISA”), including the Company’s latest Form 20-F and its registration statement on Form F-1, which are each accessible on the SEC’s website at www.sec.gov. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.Itamar Medical Company Contact Itamar Medical Ltd. Shy Basson Chief Financial Officer Phone: +972-4-617-7700 bshy@itamar-medical.comItamar Medical Investor Relations Contact (U.S.) Leigh Salvo or Caroline Paul Gilmartin Group Phone: +1-415-937-5412 investors@itamar-medical.com

  • Itamar Medical (ITMR) Soars: Stock Adds 9.7% in Session

    Itamar Medical (ITMR) Soars: Stock Adds 9.7% in Session

    Itamar Medical (ITMR) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.

  • Hedge Funds Have Never Been This Bullish On Itamar Medical Ltd. (ITMR)
    Insider Monkey

    Hedge Funds Have Never Been This Bullish On Itamar Medical Ltd. (ITMR)

    In this article you are going to find out whether hedge funds think Itamar Medical Ltd. (NASDAQ:ITMR) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks […]